Abstract
Lymphoedema is a recognised complication of axillary surgery in women with early breast cancer. Such women are widely advised to avoid venepuncture on the ipsilateral side lest this cause complications including lymphoedema. This can lead to multiple failed venepuncture attempts causing distress to both patient and healthcare professional. We reviewed current guidelines and critically appraised the evidence relating the development of lymphoedema to venepuncture to educate healthcare professionals and develop evidence-based guidelines. A systematic search of bibliographic databases was performed and an Internet search undertaken to identify patient information leaflets from societies and support groups. Seven published articles were identified together with 15 published patient information leaflets. Only one small prospective study was identified (level of evidence 2), the remainder being case–control studies (level 3) or retrospective reviews (level 4). There is no good evidence that venepuncture can precipitate lymphoedema. New, patient-centred, evidence-based recommendations for venepuncture in women with breast cancer are proposed. Whenever possible, venepuncture should be performed on the contralateral arm. If this is not readily achieved, in the absence of lymphoedema it is preferable to consider venepuncture in the ipsilateral arm or insertion of a central venous device than to make further attempts in the contralateral arm or resort to sites such as veins in the foot. In the absence of lymphoedema, venesection in the ipsilateral arm carries little, if any, risk of additional complications. We offer evidence-based, patient-centred guidelines for venepuncture in patients with breast cancer following an axillary intervention.
Similar content being viewed by others
References
Clark B, Sitzia J, Harlow W (2005) Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM 98(5):343–348
Leung N, Furniss D, Giele H (2015) Modern surgical management of breast cancer therapy related upper limb and breast lymphoedema. Maturitas 80:384–390
Petrek JA, Senie R, Peters M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92(6):1368–1377
DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500–515
Berger AM, Shuster JL, Von Roenn JH (2007) Principles and practice of palliative care and supportive oncology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 445–466
Morrell RM, Halyard MY, Schild SE et al (2005) Breast cancer-related lymphedema. Mayo Clin Proc 80(11):1480–1484
Pyszel A, Malyszczak K, Pyszel K et al (2006) Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 39:185–192
Lymphology ISO (2009) The diagnosis and treatment of peripheral lymphedema.: consensus document of the International Society of Lymphology. Lymphology 2009(42):51–60
Moffatt CJ, Franks PJ, Doherty DC (2003) Lymphoedema: an underestimated health problem. Q J Med 96:731–738
Gärtner R, Jensen M-B, Kronborg L et al (2010) Self-reported arm-lymphedema and functional impairment after breast cancer treatment—a nationwide study of prevalence and associated factors. The Breast 19:506–515
Deutsch M, Land S, Begovic M, Sharif S (2008) The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys 70:1020–1024
Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927–933
Ashikaga T, Krag DN, Land SR et al (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. Oncology 102:111–118
Geroulakos G, Robless P, Lim J (2007) Lymphoedema. Surgery 26:1
Breast Cancer Related Lymphoedema—information for doctors. Royal College of Anaesthetists. 29 Nov 2011
Villasor RP, Lewison EF (1955) Postmastectomy lymphedema; a clinical investigation into its causes and prevention. Surg Gynecol Obstet 100(6):743–752
Harbour R, Miller J (2001) A new system for grading recommendations in evidence based guidelines. BMJ 323(7308):334–336
Britton RC, Nelson PA (1962) Causes and treatment of post-mastectomy lymphedema of the arm. Report of 114 cases. JAMA 14(180):95–102
Smith J (1998) The practice of venepuncture in lymphoedema. Eur J Cancer Care (Engl) 7(2):97–98
Cole T (2006) Risks and benefits of needle use in patients after axillary node surgery. Br J Nurs 15(18):969–974
Mak SS, Lee YM, Tse SM, Ho FP, Chan E (2009) Risk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer. Hong Kong Med J 15:8–12
Winge C, Mattiasson AC, Schultz I (2010) After axillary surgery for breast cancer–is it safe to take blood samples or give intravenous infusions? J Clin Nurs 19(9–10):1270–1274
Lee TS, Kilbreath SL, Sullivan G et al (2009) Factors that affect intention to avoid strenuous arm activity after breast cancer surgery. Oncol Nurs Forum 36(4):454–462
Bates S, Sedgwick R (2013) BMJ quality improvement programme: decreasing the risk of iatrogenic lymphodema after axillary surgery: a threefold intervention. BMJ Qual Improv Rep 2:1
Blanchard DK, Donohue JH, Reynolds C, Grant CS (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482–488
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Jakes, A.D., Twelves, C. Breast cancer-related lymphoedema and venepuncture: a review and evidence-based recommendations. Breast Cancer Res Treat 154, 455–461 (2015). https://doi.org/10.1007/s10549-015-3639-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-015-3639-1